Revolut, the UK fintech, conducts a secondary share sale at a $75 billion valuation, allowing employees to sell up to 20% of their holdings.
Trump demands transparency from pharma companies on COVID drug data, amid turmoil at CDC over vaccine policy changes.
Nine former CDC directors warn that RFK Jr.'s leadership jeopardizes US public health by undermining science-based policies and replacing experts with unqualified individuals.
Revolut, the UK fintech, conducts a secondary share sale at a $75 billion valuation, allowing employees to sell up to 20% of their holdings.
Trump demands transparency from pharma companies on COVID drug data, amid turmoil at CDC over vaccine policy changes.
Nine former CDC directors warn that RFK Jr.'s leadership jeopardizes US public health by undermining science-based policies and replacing experts with unqualified individuals.